Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Coda Octopus Group, Inc. (CODA)

Coda Octopus names Mark Kelly as CFO, effective August 3, 2026

Neutral Impact 4 of 5 leadership Written later

Interim Chief Financial Officer Gayle Jardine will retire effective August 3, 2026. On July 1, 2026, Coda Octopus finalized Mark Kelly as its Chief Financial Officer, effective the same date, which gives shareholders a named successor for the finance role.

Key points

  • Gayle Jardine, interim CFO, retires effective August 3, 2026.
  • Mark Kelly's appointment was finalized July 1, 2026, effective August 3, 2026, subject to a three-month probationary period that the company may extend by two months.
  • Kelly will receive an annual base salary of £165,000 (about $218,625 at an exchange rate of $1.325), plus discretionary bonuses and a restricted stock grant valued at $40,000 that vests in two equal annual installments starting October 31,
  • Kelly was Finance Director at Medac Pharma from 2024 to 2025 and held finance roles at Chubb Insurance, Twist Bioscience and Charles River Laboratories from 2016 to 2024.

The filing

CompanyCoda Octopus Group, Inc. (CODA)
Form8-K, current report
Filed with the SECJul 6, 2026, 6:02 AM ET
Accession number0001493152-26-032038

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.